Proteomic analysis of nuclear extract of human leukaemic cells (HL60) exposed to proteasome inhibitor-MG132

被引:0
|
作者
Qian, Jun-jie [1 ]
Sun, Guo-jing [1 ]
Meng, Xiang-bing [1 ]
Song, Yi [1 ]
Mei, Zhu-zhong [1 ]
Bin Liu [1 ]
Dong, Yan [1 ]
Sun, Zhi-xian [1 ]
机构
[1] Beijing Inst Radiat Med, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:S330 / S330
页数:1
相关论文
共 50 条
  • [31] Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis
    Zheng, Zheng
    Wang, Xiang
    Chen, Donglei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (05)
  • [32] Proteasome inhibitor MG-132 enhances the expression of interleukin-6 in human umbilical vein endothelial cells: Involvement of MAP/ERK kinase
    Shibata, T
    Imaizumi, T
    Tamo, W
    Matsumiya, T
    Kumagai, M
    Cui, XF
    Yoshida, H
    Takaya, SI
    Fukuda, I
    Satoh, K
    IMMUNOLOGY AND CELL BIOLOGY, 2002, 80 (03): : 226 - 230
  • [33] Inhibition of autophagy promotes cell apoptosis induced by the proteasome inhibitor MG-132 in human esophageal squamous cell carcinoma EC9706 cells
    Liu, Donglei
    Gao, Min
    Yang, Yang
    Qi, Yu
    Wu, Kai
    Zhao, Song
    ONCOLOGY LETTERS, 2015, 9 (05) : 2278 - 2282
  • [34] The proteasome inhibitor MG-132 reveals novel mechanisms specific for the activation of IL-8 mRNA expression in human intestinal epithelial cells (IEC).
    Sakaguchi, T
    Kinugasa, T
    Nanthakumar, N
    Gu, XB
    Reinecker, HC
    GASTROENTEROLOGY, 2001, 120 (05) : A498 - A499
  • [35] Radiosensitization of Human Leukemic HL-60 Cells by ATR Kinase Inhibitor (VE-821): Phosphoproteomic Analysis
    Salovska, Barbora
    Fabrik, Ivo
    Durisova, Kamila
    Link, Marek
    Vavrova, Jirina
    Rezacova, Martina
    Tichy, Ales
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (07) : 12007 - 12026
  • [36] A CALLUNA-VULGARIS EXTRACT 5-LIPOXYGENASE INHIBITOR SHOWS POTENT ANTIPROLIFERATIVE EFFECTS ON HUMAN LEUKEMIA HL-60 CELLS
    NAJID, A
    SIMON, A
    DELAGE, C
    CHULIA, AJ
    RIGAUD, M
    EICOSANOIDS, 1992, 5 (01) : 45 - 51
  • [37] PDK1 inhibitor GSK2334470 synergizes with proteasome inhibitor MG-132 in multiple myeloma cells by inhibiting full AKT activity and increasing nuclear accumulation of the PTEN protein
    Zhang, Jin
    Yang, Chunmei
    Zhou, Fengping
    Chen, Xiaohui
    ONCOLOGY REPORTS, 2018, 39 (06) : 2951 - 2959
  • [38] Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG 132-treated human pulmonary fibroblast cells
    Park, Woo Hyun
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2011, 30 (12) : 1945 - 1954
  • [39] Proteasome inhibitor MG-132 induces non-apoptotic cell death in nuclear factor kappa B (NF-KB) dependent pancreatic cancer cells.
    Litvinov, IV
    Gates, LK
    Barve, S
    Joshi-Barve, S
    Cave, M
    FASEB JOURNAL, 2000, 14 (08): : A1519 - A1519
  • [40] The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells
    Sung, Eun-Sil
    Park, Kyung-Jin
    Choi, Hye-Ji
    Kim, Chul-Ho
    Kim, Yong-Sung
    EXPERIMENTAL CELL RESEARCH, 2012, 318 (13) : 1564 - 1576